Lemaitre Vascular (LMAT) Tops Q1 EPS by 1c; Withdraws Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
LeMaitre Vascular Announces Q1 2020 Financial Results
April 30, 2020 4:06 PM EDTBURLINGTON, Mass., April 30, 2020 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT), a provider of vascular devices, implants and services, today reported Q1 2020 results and announced a $0.095/share quarterly dividend.
Q1 2020 Results
Record sales of $30.6mm, +7% (-1% organic) vs. Q1 2019Operating income of $4.4mm, -2%Net income of $3.2mm, -10%Earnings of $0.16 per diluted share, -11%EBITDA of $5.7mm, +1%March 31, 2020 cash & equivalents of $30.6mmThe Company posted record sales in the Americas (+12%) and Europe/Middle East/Africa (+3%), offset by Asia/Pac (-11%). Sales growth... More
